Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables - Other (2016 - 2022)

Historic Receivables - Other for Rockwell Medical (RMTI) over the last 8 years, with Q3 2022 value amounting to $7.4 million.

  • Rockwell Medical's Receivables - Other rose 2205.1% to $7.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $7.4 million, marking a year-over-year increase of 2205.1%. This contributed to the annual value of $5.9 million for FY2021, which is 4176.46% up from last year.
  • Latest data reveals that Rockwell Medical reported Receivables - Other of $7.4 million as of Q3 2022, which was up 2205.1% from $8.1 million recorded in Q2 2022.
  • Rockwell Medical's 5-year Receivables - Other high stood at $8.1 million for Q2 2022, and its period low was $5122.0 during Q3 2019.
  • In the last 5 years, Rockwell Medical's Receivables - Other had a median value of $5.4 million in 2021 and averaged $4.6 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first plummeted by 9993.25% in 2019, then surged by 8051304.18% in 2020.
  • Quarter analysis of 5 years shows Rockwell Medical's Receivables - Other stood at $7.0 million in 2018, then tumbled by 39.79% to $4.2 million in 2019, then fell by 0.76% to $4.2 million in 2020, then surged by 41.76% to $5.9 million in 2021, then rose by 24.59% to $7.4 million in 2022.
  • Its last three reported values are $7.4 million in Q3 2022, $8.1 million for Q2 2022, and $7.1 million during Q1 2022.